Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Biostatistics & Modelling Domain, Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Liver Transpl. 2024 May 1;30(5):493-504. doi: 10.1097/LVT.0000000000000303. Epub 2023 Nov 29.
The scarcity of liver grafts has prompted developments in living donor liver transplantations (LDLT), with previous literature illustrating similar outcomes in recipients compared to deceased donor transplants. However, significant concerns regarding living donor morbidity and mortality have yet to be examined comprehensively. This study aims to provide estimates of the incidence of various outcomes in living liver donors. In this meta-analysis, Medline and Embase were searched from inception to July 2022 for articles assessing the incidence of outcomes in LDLT donors. Complications in the included studies were classified into respective organ systems. Analysis of incidence was conducted using a generalized linear mixed model with Clopper-Pearson intervals. Eighty-seven articles involving 60,829 living liver donors were included. The overall pooled incidence of complications in LDLT donors was 24.7% (CI: 21.6%-28.1%). The incidence of minor complications was 17.3% (CI: 14.7%-20.3%), while the incidence of major complications was lower at 5.5% (CI: 4.5%-6.7%). The overall incidence of donor mortality was 0.06% (CI: 0.0%-0.1%) in 49,027 individuals. Psychological complications (7.6%, CI: 4.9%-11.5%) were the most common among LDLT donors, followed by wound-related (5.2%, CI: 4.4%-6.2%) and respiratory complications (4.9%, CI: 3.8%-6.3%). Conversely, cardiovascular complications had the lowest incidence among the subgroups at 0.8% (CI: 0.4%-1.3%). This study presents the incidence of post-LDLT outcomes in living liver donors, illustrating significant psychological, wound-related, and respiratory complications. While significant advancements in recent decades have contributed towards decreased morbidity in living donors, our findings call for targeted measures and continued efforts to ensure the safety and quality of life of liver donors post-LDLT.
供肝短缺促使人们开展活体肝移植(LDLT),既往文献表明,与尸体供肝移植相比,LDLT 受者的结局相似。然而,活体供者发病率和死亡率方面的一些重大问题尚未得到全面研究。本研究旨在评估活体肝供者各种结局的发生率。本荟萃分析检索了从建库至 2022 年 7 月的 Medline 和 Embase 数据库,以评估 LDLT 供者结局发生率的文章。将纳入研究中的并发症分为相应的器官系统。采用广义线性混合模型和 Clopper-Pearson 区间进行发生率分析。共纳入 87 篇涉及 60829 例活体肝供者的文章。LDLT 供者的总体并发症发生率为 24.7%(95%CI:21.6%-28.1%)。轻微并发症发生率为 17.3%(95%CI:14.7%-20.3%),而严重并发症发生率较低,为 5.5%(95%CI:4.5%-6.7%)。49027 例供者的总死亡率为 0.06%(95%CI:0.0%-0.1%)。LDLT 供者中最常见的心理并发症为 7.6%(95%CI:4.9%-11.5%),其次为与伤口相关的并发症(5.2%,95%CI:4.4%-6.2%)和呼吸系统并发症(4.9%,95%CI:3.8%-6.3%)。相反,心血管并发症的发生率在亚组中最低,为 0.8%(95%CI:0.4%-1.3%)。本研究报告了活体肝移植后供者结局的发生率,表明存在显著的心理、与伤口相关和呼吸系统并发症。尽管近几十年来取得了显著进展,降低了活体供者的发病率,但我们的研究结果表明,需要采取有针对性的措施并持续努力,以确保 LDLT 后肝供者的安全和生活质量。